peiminine has been researched along with alpha-synuclein in 1 studies
| Studies (peiminine) | Trials (peiminine) | Recent Studies (post-2010) (peiminine) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
|---|---|---|---|---|---|
| 69 | 0 | 39 | 10,821 | 29 | 8,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, YT; Fu, RH; Hsu, YL; Hung, HS; Kuo, YH; Lin, SZ; Liu, SP; Shyu, WC; Tsai, CW | 1 |
1 other study(ies) available for peiminine and alpha-synuclein
| Article | Year |
|---|---|
Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Apoptosis Regulatory Proteins; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cevanes; Dopamine; Dopaminergic Neurons; Nerve Degeneration; Parkinson Disease; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Substantia Nigra; Ubiquitin; Ubiquitin-Protein Ligases; X-Linked Inhibitor of Apoptosis Protein | 2021 |